SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 406 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $90,053,342 | -18.9% | 742,892 | -23.4% | 0.02% | -18.2% |
Q2 2023 | $111,002,886 | -18.4% | 969,288 | -1.8% | 0.02% | -24.1% |
Q1 2023 | $136,020,507 | -18.6% | 986,872 | -23.5% | 0.03% | -23.7% |
Q4 2022 | $167,070,954 | +33.0% | 1,289,327 | +13.4% | 0.04% | +31.0% |
Q3 2022 | $125,650,000 | +15.5% | 1,136,693 | -21.7% | 0.03% | +16.0% |
Q2 2022 | $108,821,000 | +50.7% | 1,451,723 | +57.1% | 0.02% | +66.7% |
Q1 2022 | $72,188,000 | -26.1% | 924,056 | -14.8% | 0.02% | -21.1% |
Q4 2021 | $97,642,000 | +11.0% | 1,084,305 | +14.0% | 0.02% | +5.6% |
Q3 2021 | $87,957,000 | +16.9% | 951,095 | -1.8% | 0.02% | +12.5% |
Q2 2021 | $75,261,000 | +18.8% | 968,099 | +13.9% | 0.02% | +6.7% |
Q1 2021 | $63,366,000 | -76.7% | 850,212 | -46.7% | 0.02% | -78.6% |
Q4 2020 | $272,207,000 | +15.8% | 1,596,617 | -4.6% | 0.07% | +6.1% |
Q3 2020 | $235,077,000 | -13.5% | 1,673,981 | -1.2% | 0.07% | -19.5% |
Q2 2020 | $271,759,000 | +37.1% | 1,694,888 | -16.3% | 0.08% | +17.1% |
Q1 2020 | $198,181,000 | -11.1% | 2,025,972 | +17.3% | 0.07% | +25.0% |
Q4 2019 | $222,959,000 | +92.6% | 1,727,820 | +12.4% | 0.06% | +69.7% |
Q3 2019 | $115,781,000 | -20.6% | 1,537,198 | +60.1% | 0.03% | -21.4% |
Q2 2019 | $145,899,000 | +21.1% | 960,180 | -5.0% | 0.04% | +16.7% |
Q1 2019 | $120,450,000 | +64.2% | 1,010,573 | +50.3% | 0.04% | +56.5% |
Q4 2018 | $73,357,000 | -26.0% | 672,204 | +9.5% | 0.02% | -11.5% |
Q3 2018 | $99,110,000 | -14.4% | 613,644 | -29.9% | 0.03% | -16.1% |
Q2 2018 | $115,752,000 | +128.8% | 875,714 | +28.2% | 0.03% | +138.5% |
Q1 2018 | $50,598,000 | +15.0% | 682,929 | -13.6% | 0.01% | +18.2% |
Q4 2017 | $44,001,000 | -24.2% | 790,815 | -38.2% | 0.01% | -21.4% |
Q3 2017 | $58,046,000 | +106.7% | 1,279,663 | +53.6% | 0.01% | +100.0% |
Q2 2017 | $28,079,000 | +49.0% | 832,968 | +30.8% | 0.01% | +40.0% |
Q1 2017 | $18,851,000 | +70.9% | 636,892 | +58.4% | 0.01% | +66.7% |
Q4 2016 | $11,030,000 | -70.5% | 402,063 | -33.9% | 0.00% | -72.7% |
Q3 2016 | $37,349,000 | +126.1% | 608,183 | -29.8% | 0.01% | +120.0% |
Q2 2016 | $16,517,000 | +139.9% | 866,176 | +145.6% | 0.01% | +150.0% |
Q1 2016 | $6,885,000 | -21.2% | 352,727 | +55.8% | 0.00% | -33.3% |
Q4 2015 | $8,735,000 | +84.2% | 226,385 | +53.3% | 0.00% | +200.0% |
Q3 2015 | $4,742,000 | +40.6% | 147,699 | +33.3% | 0.00% | 0.0% |
Q2 2015 | $3,372,000 | +162.6% | 110,808 | +14.6% | 0.00% | – |
Q1 2015 | $1,284,000 | +2.0% | 96,661 | +11.1% | 0.00% | – |
Q4 2014 | $1,259,000 | -83.0% | 86,981 | -75.2% | 0.00% | -100.0% |
Q3 2014 | $7,415,000 | +359.4% | 351,424 | +548.7% | 0.00% | – |
Q2 2014 | $1,614,000 | -23.8% | 54,176 | -38.6% | 0.00% | – |
Q1 2014 | $2,119,000 | -61.9% | 88,168 | -67.7% | 0.00% | -100.0% |
Q4 2013 | $5,555,000 | -34.7% | 272,748 | +51.5% | 0.00% | -33.3% |
Q3 2013 | $8,503,000 | +53.6% | 180,035 | +23.7% | 0.00% | +50.0% |
Q2 2013 | $5,537,000 | +2236.3% | 145,565 | +1483.6% | 0.00% | – |
Q4 2012 | $237,000 | -78.5% | 9,192 | -87.0% | 0.00% | – |
Q3 2012 | $1,100,000 | – | 70,805 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |